Ads
related to: what is psoriasis
Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 3 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
Yale dermatologist points to link between skin con | Newswise
Newswise· 20 hours agoDr. Jeffrey Cohen, Assistant Professor and Director of the Psoriasis Treatment Program at Yale...
Cryogenic chambers and infrared capsules. This ‘fitness hotel’ is taking wellness tech to the next...
CNN via AOL· 42 minutes agoWhile the “dome” acts as a sauna, a light therapy helmet provides a touchless facial, using red...
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 2 days agoThe study led by researchers at the Universities of Oxford, University College Dublin and supported...
Barstool's Dave Portnoy had basal cell carcinoma removed. Experts explain the skin cancer's risks,...
Yahoo Life Style via AOL· 5 hours agoBCCs can also itch, ooze, bleed or scab over. In some cases they may grow over time. Skin Cancer...
Certain Clinical Factors Tied to Poor Response to Biologics for Psoriasis
MedPage Today· 3 days agoPrevious exposure to biologics, higher BMI, smoking all negatively linked to response
13 Best Shampoos for Thinning Hair, According to Hair and Skin Experts
Prevention via AOL· 10 hours agoWe reviewed the best shampoos for thinning hair, per dermatologists. Our top picks reign from brands...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 12 hours agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque psoriasis, and Crohn ...
IgG4-Related Disease Affects Men More Often, More Severely
Medscape· 20 hours agoA recent study highlighted sex-based differences in manifestations of IgG4-related disease.
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 5 hours agoJohnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA ...
Ads
related to: what is psoriasis